A 9-month-old child from urban Delhi presents with fever, rash (maculopapular, starting on face and spreading downward), cough, and coryza. The child has received all vaccines as per the National Immunisation Schedule up to 9 months. The mother reports that the child was in contact with an unvaccinated cousin who had similar symptoms 10 days ago. Which investigation is most appropriate to confirm the suspected diagnosis?

Explanation

## Diagnosis of Measles in a Vaccinated Child ### Clinical Presentation The child presents with the classic triad of measles: 1. **Prodrome:** Fever, cough, coryza (3 Cs) 2. **Pathognomonic sign:** Koplik spots (not mentioned but may be present on buccal mucosa 2–3 days before rash) 3. **Rash:** Maculopapular, cephalocaudal spread (face → trunk → extremities) Contact with an unvaccinated child 10 days prior and the child's own vaccination status (received MMR at 9–12 months per NIS) suggest **vaccine failure** or **breakthrough measles**. ### Why IgM Serology After 4 Days of Rash is the Investigation of Choice **Key Point:** Measles diagnosis depends on the timing of specimen collection: | Investigation | Optimal Timing | Sensitivity | Specificity | Use Case | |---|---|---|---|---| | **RT-PCR (nasopharyngeal)** | Within 3 days of rash onset | 95% | 98% | Early diagnosis (prodrome/early rash) | | **IgM serology** | After 4 days of rash onset | 90% | 99% | Confirmed rash phase (current case) | | **IgG serology** | After 2–3 weeks | High | High | Immunity assessment, epidemiology | | **Viral culture** | Nasopharynx/throat | Low | High | Slow, not practical for acute diagnosis | **High-Yield:** In this 9-month-old presenting with established rash (day 1 of rash onset is unclear, but contact was 10 days ago, suggesting rash is now in its 2nd–3rd day or beyond), **IgM serology collected after 4 days of rash onset** is the most appropriate investigation because: 1. IgM appears 3–4 days after rash onset and peaks at 1–2 weeks 2. At this timepoint, IgM is highly specific (99%) and sensitive (90%) 3. It confirms measles diagnosis without requiring early nasopharyngeal swab 4. The rash is already established, making clinical diagnosis likely; serology confirms it ### Diagnostic Algorithm for Measles ```mermaid flowchart TD A[Suspected measles: fever + 3Cs + rash]:::outcome --> B{Days since rash onset?}:::decision B -->|0-3 days: early rash| C[RT-PCR from nasopharyngeal swab]:::action B -->|4+ days: established rash| D[IgM serology]:::action C --> E{RT-PCR positive?}:::decision D --> F{IgM positive?}:::decision E -->|Yes| G[Confirm measles]:::outcome F -->|Yes| G E -->|No| H[Repeat serology or RT-PCR]:::action F -->|No| H ``` ### Why RT-PCR Within 3 Days is NOT the Best Choice Here **Clinical Pearl:** RT-PCR is the gold standard for early diagnosis (prodrome to early rash, days 0–3). However: - The clinical presentation suggests the rash is already established (not in the first 3 days) - The contact was 10 days ago; measles incubation is 10–14 days, so rash likely appeared 8–10 days after contact - If the rash is already 4+ days old, RT-PCR sensitivity drops as viral load decreases in nasopharynx - IgM serology is more practical and reliable at this stage **Warning:** Timing matters. RT-PCR is excellent for early diagnosis but loses sensitivity after day 3 of rash. IgM becomes reliable after day 4. ### Why Viral Culture is Inappropriate **Key Point:** Measles virus culture: - Is slow (takes 1–2 weeks) - Has low sensitivity in clinical samples - Is not practical for acute diagnosis - Requires BSL-3 laboratory facilities (rarely available) Culture is used for research and epidemiological surveillance, not clinical diagnosis. ### Why Chest X-ray Alone is Inadequate Chest X-ray may show pneumonia (a common complication of measles) but: - Does NOT confirm measles diagnosis - Cannot differentiate measles pneumonia from other viral or bacterial pneumonia - Should be performed if respiratory compromise is suspected, but only **after** confirming measles with serology or RT-PCR ### National Immunisation Schedule Context **High-Yield:** Per NIS: - **MMR vaccine:** Given at 9–12 months (1st dose) and 16–24 months (2nd dose) - This child is at the age of 1st MMR dose - Breakthrough measles can occur if: - Vaccination was recent and immune response not yet developed - Vaccine was not stored properly (cold chain failure) - Child had primary vaccine failure (rare, ~5% of recipients) - Exposure was very heavy (high viral load from unvaccinated contact) **Key Point:** Vaccination does NOT guarantee immunity; serological confirmation is needed to diagnose breakthrough measles.